§ 809.3. Definitions.
182 words·~1 min read·
/us/cfr/t21/s§ 809.3·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body. These products are devices as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act (the act), and may also be biological products subject to section 351 of the Public Health Service Act.
(b)A product class is all those products intended for use for a particular determination or for a related group of determinations or products with common or related characteristics or those intended for common or related uses. A class may be further divided into subclasses when appropriate.
(c)[Reserved]
(d)Act means the Federal Food, Drug, and Cosmetic Act. [41 FR 6903, Feb. 13, 1976, as amended at 45 FR 7484, Feb. 1, 1980; 89 FR 37445, May 6, 2024; 90 FR 45136, Sept. 19, 2025]
Connections16 cite this
Cited by 16 sections · top 10
register
- Rules and RegulationsDirect final rule
- NoticesNotice of availability
- Rules and RegulationsProposed rule
- NoticesNotice of Demonstration
- NoticesInterim final rule with request for comments
- NoticesFinal notice
- Rules and RegulationsFinal rule
- Proposed RulesInterim final rule with comment period
- Presidential DocumentsFinal rule
- Proposed RulesProposed rule
Citation graph
cites case law
§ 809.3
Definitions.
Fed. Reg.×16
Cites 0Cited by 16 across 1 source